PT-141 is a synthetic analogue of alpha-MSH acting on melanocortin receptors (MC3R and MC4R) in the CNS to stimulate sexual arousal and desire. Unlike PDE5 inhibitors, PT-141 works centrally – addressing desire at the neurological level making it effective for both men and women. FDA-approved (as Vyleesi) for HSDD in premenopausal women.
Key Benefits
- Centrally acting
- stimulates sexual desire and arousal at the brain level
- Effective in both men and women
- FDA-approved analogue for HSDD in women (Vyleesi)
- Works independently of vascular mechanisms
- Enhanced sexual satisfaction and performance
